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investigators§ London and Bristol, United KingdomBackground: Latent class analysis (LCA) has been used
extensively to identify (latent) phenotypes of childhood
wheezing. However, the number and trajectory of discovered
phenotypes differed substantially between studies.
Objective: We sought to investigate sources of variability
affecting the classification of phenotypes, identify key time
points for data collection to understand wheeze heterogeneity,
and ascertain the association of childhood wheeze phenotypes
with asthma and lung function in adulthood.
Methods: We used LCA to derive wheeze phenotypes among
3167 participants in the ALSPAC cohort who had complete
information on current wheeze recorded at 14 time points from
birth to age 16½ years. We examined the effects of sample size
and data collection age and intervals on the results and
identified time points. We examined the associations of derived
phenotypes with asthma and lung function at age 23 to 24 years.
Results: A relatively large sample size (>2000) underestimated
the number of phenotypes under some conditions (eg, number of
time points <11). Increasing the number of data points resulted
in an increase in the optimal number of phenotypes, but an
identical number of randomly selected follow-up points led to
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https://doi.org/10.1016/j.jaci.2018.10.059informative time points (months 18, 42, 57, 81, 91, 140, 157, and
166). The proportion of asthmatic patients at age 23 to 24 years
differed between phenotypes, whereas lung function was lower
among persistent wheezers.
Conclusions: Sample size, frequency, and timing of data
collection have a major influence on the number and type of
wheeze phenotypes identified by using LCA in longitudinal data.
(J Allergy Clin Immunol 2019;143:1783-90.)
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Wheeze is a common symptom in the early years of life, with
nearly one third of children experiencing it at least once before their
third birthday.1-3 Although the symptoms of most infants with
wheeze seem to remit by the time the child reaches school age,4
infantile wheeze can also persist into later childhood and adulthood
after a period of remission.5,6 Conversely, the majority of patients
with persistent asthma start wheezing in early childhood.2 However,
at the onset of symptoms, patients with ‘‘transient wheeze’’ and
‘‘persistent wheeze’’ look very similar, and it is difficult to predict
which of the early childhood wheezers will stop wheezing (and
when) and which will have persistent wheezing and asthma.
Understanding the heterogeneity of wheezing disorders and
distinguishing wheeze phenotypes in early childhood is critical to
developing interventions targeted at those who will persist with
wheezing into later childhood and to avoid overtreatment of
patients with transient wheeze.7 Over the last 2 decades, substan-
tial effort has been devoted to understanding the heterogeneity of
childhoodwheezing illness.7-10 In general, population-based birth
cohorts are regarded as optimal data sources for understanding
temporal patterns of wheezing and relating them to different
risk factors because the information is collected prospectively
and therefore free from recall bias.11
The initial approach of hypothesis testing using data on
wheezing collected at the ages of 3 and 6 years in the Tucson
Children’s Respiratory Study (TCRS) described 3 wheeze
phenotypes: transient early, late onset, and persistent.2 This
finding was confirmed in several independent cohorts.3,12,13 Sub-
sequently, the methodology to discover ‘‘wheeze phenotypes’’
was extended to the use of unsupervised data-driven approaches,
such as latent class analysis (LCA).1,14-18 These analyses revealed
a different structurewithin the data and suggested the existence of
119,20 or 2 further intermediate phenotypes.1,17,18 It is important to
emphasize that although wheeze phenotypes derived from
different analyses tend to share the same nomenclature, pheno-
types with the same assignment often differ substantially in terms
of the age of onset, temporal trajectory, distributions within a pop-
ulation,8 and associated risk factors, making comparison between1783
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example, late-onset wheezers were reported to start experiencing
symptoms after the age of 3,19 4,16 or 513 years in different studies.
Inconsistencies between studies can be partly attributed to differ-
ences in study design or could be due to true differences between
different populations. However, this seems unlikely because most
evidence comes from broadly similar population-based studies
with comparable ethnic mixes.
If we are to understand factors associated with patterns of
wheezing with different long-term consequences, then pheno-
types must be consistent and reproducible. Despite the wide-
spread use of LCA, little is known about the external factors that
influence the outcomes of LCA models in phenotype identifica-
tion.We propose that sample size and the timing and frequency of
data collection affect the number and type of discovered wheeze
phenotypes in LCA and that not all time points carry useful
information (and therefore some might be redundant or even
cause uncertainty in the results).
To provide a better understanding of the influence of input data
characteristics on the identified longitudinal trajectories of
wheezing, we investigated the effect of the number of data points,
age at which information was collected, and sample size on the
number and/or nature of wheeze phenotypes discovered by LCA.
We also sought to identify data collection points, which are most
informative in distinguishing wheeze phenotypes.METHODS
Study design, setting, and participants
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a
population-based birth cohort established in 1991 in Avon, United Kingdom.
It recruited 14,701 children born between April 1, 1991, and December 31,
1992. Ethical approval for the study was obtained from the ALSPAC Ethics
and LawCommittee and local research ethics committees. Details of the study
protocol can be found elsewhere.21 The study Web site contains details of all
the data that are available through a fully searchable data dictionary at
www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/.Data sources and definition of outcomes
Participating mothers were sent a self-completion questionnaire about the
health of their children at 14 time points from birth to age 16½years:months 6,
18, 30, 42, 57, 69, 81, 91, 103, 128, 140, 157, 166, and 198. Current wheezing
was defined as a positive answer to the following question: ‘‘In the last
12 months has he/she had any periods when there was wheezing or wheezing
with whistling on his/her chest when he/she breathed?’’22
Study subjects attended a research clinic at age 23 to 24 years in which lung
function was measured by using spirometry.23,24 Postbronchodilator FEV1
was ascertained 15 minutes after administration of 400 mg of salbutamol.
We expressed FEV1 as percent predicted values against Global Lung Function
Initiative curves.25 Self-reported asthma everwas defined as a positive answer
to the following question: ‘‘Have you ever had asthma?’’ Self-reported current
asthma was defined at age 23 years as asthma ever together with a positive
answer to either of the following questions: ‘‘Have you had any wheezing orwhistling in the past 12 months?’’ or ‘‘Have you taken asthma medication in
the last 12 months?’’Statistical analysis
Children with complete reports of wheezing at all 14 time points from birth
to age 16½ years (n 5 3167) were included in the analysis to obtain better
representation of the latent structure. We performed LCA to investigate how
latent class subpopulation structure varied by the timing and frequency of
observations. Starting with a latent model including 4 phenotypes, we
compared models with varying sample sizes (3167, 2500, 2000, 1500, 1000,
and 500), numbers of latent classes (4-6), and numbers of time points (14, 11,
8, and 6) based on their statistical fit, including the Akaike information
criterion, Bayesian information criterion (BIC), Lo–Mendell–Rubin and
bootstrapped likelihood ratio, model quality (model entropy), and interpret-
ability. The best-fitting model in each run was selected based on the lowest
BIC. We then repeated our analyses among 12,290 participants with at least 2
questionnaire responses. We identified critical data collection points for
identification of distinct phenotypes of wheezing based on stochastic
evolutionary search through a genetic algorithm (see the Methods section in
this article’s Online Repository at www.jacionline.org for more details on
the methodology for selection of informative data collection points). The
adjusted Rand index (ARI) was used as a similarity measure when comparing
different clustering results. Variable specific entropy values were used to show
how well individual data collection points identify the latent classes. We
calculated CIs for the difference of population proportions to compare the
frequency of participants with asthma at age 23 years between different
phenotypes. Differences in lung function were tested by using 1-way ANOVA
and the Tukey honestly significant difference test. All analyses were
performed in Stata software (version 15), Mplus 8, and R software by using
the packages poLCA,26 DiagrammeR, and LCAvarsel.27RESULTS
A total of 3167 participants had complete reports of wheeze at
all 14 time points. In line with our previous results,17,18 the
best-fitting model resulted in 6 distinct wheeze phenotypes:
never/infrequent wheezing; persistent wheezing; 2 early-onset
transient classes (early-onset preschool remitting and early-
onset midchildhood remitting); and 2 late-onset persisting classes
(school-age onset and late-childhood onset).Influence of sample size
We varied the sample size from 3167 to 500 and developed 11
different models based on randomly selected subsamples of 6
different sizes (n 5 500, 1000, 1500, 2000, 2500, and 3167),
holding all else constant. Fig 1, A, shows the best-fitting models
based on different sample sizes and the prevalence of each
phenotype based on the estimated model. Four phenotypes
(never/infrequent, persistent, transient early, and late onset)
were identified with a sample size of 500. The best-fitting model
based on 1000 participants resulted in 4 to 5 phenotypes.
Larger sample sizes (>_2000 participants) were needed to detect
smaller phenotypes (<5% frequency). LCA identified 6 latent
wheeze phenotypes in samples of 2000 or more children with
complete data (Fig 1, A) and in samples of 5000 or more children
with incomplete data (see Fig E1 in this article’s Online
Repository at www.jacionline.org).Influence of data collection frequency
We then varied the frequency of data collection time points
from 6 to 14 and developed 10 different models based on
FIG 1. Optimal number, shape, and prevalence of wheeze phenotypes identified by using LCA. A, Eleven
latent models based on randomly selected subsamples of 6 different sample sizes (n 5 500, 1000, 1500,
2000, 2500, and 3167) while maintaining a constant number of follow-up points (14 time points). B, Ten
latent models based on randomly selected time points (6, 8, 11, and 14 time points) while maintaining a
constant sample size (n 5 3167). C, Twelve latent models based on randomly selected subsamples of 4
different sample sizes (n 5 500, 1500, 2500, and 3167) and different numbers of time points (6, 8, and 11
time points).
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TABLE I. Clustering summary of the LCA model fitted to the
data subset (8 time points identified through a genetic
algorithm search) and its comparison with the model fitted to
the full data set (14 data collection points) based on 3167
participants with complete information on current wheeze
recorded at 14 time points
Model characteristics Variable selection (stochastic search)
No. of classes 6 Selected time points (mo) Univariate entropy
BIC 15,508 18 0.502
42 0.581
Entropy 0.87 57 0.590
81 0.578
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sample size (n 5 3167). Adding more time points to the latent
model increased the number of wheeze phenotypes that were
identified (Fig 1, B). However, in some cases an identical number
of (randomly selected) data collection points (eg, 11 time points)
resulted in different optimal numbers of phenotypes, depending
on intervals between time points. This suggests that, in addition
to sampling frequency, timing and distribution of time points at
which data are collected can influence wheeze phenotype
identification and that there might be critical data collection
points that are more informative in distinguishing wheeze
phenotypes.Rand Index 0.82 91 0.588
ARI 0.64 140 0.549
Jaccard index 0.70 157 0.576
166 0.582Combined effects of sample size and data collection
frequency
To examine how both the frequency of data collection (number
of time points) and the size of the studied population affects the
optimal number, trajectory, and frequency of the identified
phenotypes, we varied the number of data collection points
from 6 to 11 and randomly selected subsamples of 4 different
sizes, resulting in a total of 12 data conditions (Fig 1, C).
Models with small sample sizes (n < 2500) did not identify
low-frequency phenotypes (<5%), regardless of the frequency of
data sampling. However, there was a clear link between sample
size, number of data points, and optimal number of wheeze
phenotypes. Models with sample sizes of 2500 or greater
identified 6 phenotypes when the number of data collection
points included in the analysis was relatively high. However,
models with decreasing numbers of data points were unable to
detect 6 phenotypes, and models with the same sample size did
not identify small phenotypes (<5% frequency) under certain
conditions (eg, number of time points < 11).Selection of the most informative data collection
points
Fig E2 in this article’s Online Repository at www.jacionline.
org shows the correlations (phi coefficients) between wheeze
reports at different time points. Time points close to each other
were moderately correlated (eg, months 157 and 166 and months
81 and 91), suggesting that some of the adjacent time points
convey similar information. To discard the noninformative data
collection points, we performed stochastic evolutionary search
through a genetic algorithm, which retained 8 informative time
points (months 18, 42, 57, 81, 91, 140, 157, and 166), and 6
were dropped as uninformative (months 6, 30, 69,103, 128, and
198). Comparing the clustering of the models using 8 time points
with the clustering from themodel using the full data set showed a
satisfactory level of agreement, with a Rand index and ARI of 82
and 64%, respectively (Table I).Latent transition probabilities with increasing
numbers of classes
To understand how the trajectories and estimated phenotypes
changed over a sequence of increasing numbers of classes and
how children move from one class to another in models with
increasing numbers of classes, we developed 3 LCA models with
4, 5, and 6 classes. Persistent and never/infrequent wheezing
classes had similar patterns in all 3 models, with a slight decreasein estimated prevalence from a 4- to 6-class solution (Fig 2, A).
With the addition of a fifth latent class, transient early wheezing
was divided into 3 remitting classes (preschool and midchildhood
resolution; Fig 2, B), whereas late-onset wheezing remained
almost identical. The addition of a sixth class resulted in division
of late-onset wheezing into 2 similarly sized subgroups
(school-age and late-childhood onset; Fig 2,C). We then assigned
participants to the most likely phenotype based on the maximum
membership probability and calculated transition probabilities
reflecting the proportion of participants moving from one
phenotype to another when the number of phenotypes increased
from 4 up to 6. Fig 3 shows whether members of distinct
phenotypes remained in the same phenotype or shift into another
one (either existing or newly formed) with increasing numbers of
phenotypes. The figure also demonstrates from where the
intermediate phenotypes arise and which phenotypes become
separated or remain undivided with increasing numbers of latent
classes. The results based on analysis of participants with
incomplete reports of wheezing (12,290 participants with >_2
responses to questionnaires about wheezing) did not materially
differ from those obtained among children with a complete data
set and are presented in Figs E1 and E3-E6 in this article’s Online
Repository at www.jacionline.org.Asthma and lung function in adulthood in patients
with different wheeze phenotypes
Of 3797 participants who attended follow-up at age 23 to
24 years, 1492 had complete reports of wheezing (14 points), of
whom 240 (16%) reported current asthma; 1345 had valid lung
function. The proportion of subjects with current asthma was
greatest in the persistent wheeze phenotype (99.7%, Table II). In
the 2 early-onset transient phenotypes, the proportion of
asthmatic patients was significantly greater in midchildhood-
remitting (60.4%) compared with the preschool-remitting
(6.4%) phenotypes (mean difference, 0.5; 95% CI, 0.40-0.68;
P < .0001). In the 2 late-onset phenotypes the proportion of
asthmatic patient was significantly greater in the school-age onset
(88.4%) compared with late-childhood onset (68.1%) phenotypes
(mean difference, 0.20; 95% CI, 0.05-0.36; P < .02).
Prebronchodilator and postbronchodilator lung function differed
FIG 2. Estimated prevalence of wheezing for each wheeze phenotype in 4, 5, and 6 latent class solutions
identified by using LCA.
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respectively, ANOVA) and was significantly less in the persistent
wheezing and early-onset preschool remitting wheeze
phenotypes compared with the never/infrequent wheeze
phenotype, with little evidence of differences between other
phenotypes (Table III and see Tables E1-E3 in this article’s Online
Repository at www.jacionline.org). The preschool-onset
remitting phenotype mostly overlapped with no asthma (94%),
but prebronchodilator and postbronchodilator lung function at
age 24 years was significantly less in this class compared with
the never/infrequent wheeze phenotype.DISCUSSION
Key results
Our results suggest that the number and nature of wheeze
phenotypes from infancy to adolescence identified by using LCA
are dependent on several factors, including sample size,
frequency, timing and distribution of data collection time points,
model dimensionality, and the combination of these factors.
Transition analysis revealed that subjects assigned to the never or
persistent wheeze phenotypes tend to stay in these phenotypes,
whereas most of the switching goes on in the intermediate classes.
Given the strong interplay between the birth cohort design
(including the number of participants, data collection frequency,
and distribution) and the optimal number of phenotypes identified
by means of developmental trajectory modeling, care should be
taken when interpreting wheeze phenotypes emerging from small
studies with few data collection points. When the sample size issmall, a wheeze phenotype that exists in the population might be
unidentifiable, whereas excessive data collection can result in
identification of trivial or clinically irrelevant phenotypes. In
general, increasing data collection frequency helps detect more
complex structure and larger numbers of phenotypes by capturing
less frequently observed subgroups. However, it also increases the
risk of violating the fundamental assumption of LCA modeling
where indicator variables (eg, presence/absence of wheezing at
subsequent ages) are independent of each other. When frequent
data collection and large sample sizes are not obtainable,
collecting data at critical time points might help counterbalance
the effects of suboptimal conditions (eg, smaller sample size and
infrequent data collection). In our study the time points that
proved most informative in distinguishing wheeze phenotypes
were months 18, 42, 57, 81, 91, 140, 157, and 166.Limitations
There are several limitations to our findings. Despite latent
models’ usefulness in disentangling disease complexity, 1 unre-
solved issue in the application of LCA is that there is not one
commonly accepted statistical indicator for deciding on the
number of subgroups in a study population. The limitation of
this study is that we do not know howmany true phenotypes there
are, and we assumed that the classification obtained on the largest
sample and using all time points corresponded to the best
available approximation of the ‘‘true classification.’’ In the
absence of clear statistical requirements for identifying clinically
important groups of small size, validation of the phenotypes with
FIG 3. Assignment of children into distinct wheeze phenotypes over a sequence of latent class models with
4, 5, and 6 classes based on most likely class membership (cohort of 3167 children with complete reports of
wheezing at 14 time points). Ellipse nodes show class membership (most likely phenotype), whereas values
along the arrow represent the percentage of children moving from one class to another in models with an
increasing number of classes.
TABLE II. Proportion of asthmatic patients at age 23 to 24 years in each phenotype
Wheeze phenotypes,
0-16½ y
Self-reported asthma ever Current asthma at age 23 y Asthma medication use at age 23 y
No. of asthmatic
patients/total Percentage*
No. of asthmatic
patients/total Percentage*
No. of medication
users/total Percentage*
Never infrequent 105/1111 9.4 50/985 5.1 33/985 3.3
Transient early
Preschool remitting 54/355 15.1 19/295 6.4 9/295 3.2
Midchildhood remitting 72/95 75.3 30/49 60.4 14/49 29.5
Late onset
School-age onset 56/61 91.3 38/43 88.4 25/43 58.3
Late-childhood onset 58/82 70.0 38/55 68.1 25/55 45.3
Persistent wheeze 81/82 98.5 65/65 99.7 53/65 82.1
*The percentage is estimated from weighted cross-tabulations.
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relevance. However, we acknowledge that in our study
information on asthma and lung function measures at age 23 to
24 years was available for approximately 45% of participants
used to derive wheeze phenotypes.
Another limitation is that we could only vary conditions using
the sampling framework that was available to us, which was fixed
by the study design, and therefore this analysis has limited direct
application to other studies that have used different sampling
frames. We also acknowledge that the definition of current
wheezing, which we used in our models, is based on parental
reporting using validated questionnaires (as in most other
epidemiologic studies) and that this might lead to overestimation
of the true prevalence.28
As most previous studies, we used information on current
wheeze for our modeling. It is possible that a more holisticexamination of other features (eg, frequency and severity of
wheezing) and/or other symptoms (eg, cough, atopic
dermatitis, and rhinitis)22 and lung function29 might allow
better distinction of the underlying pathophysiologic
mechanisms.
The key advantage of our study is the large sample size with
complete data on wheezing collected frequently and
prospectively. Another advantage is that participants were
followed from birth to late adolescence, covering a longer period
compared with most prior studies.1,13,18,19,30
Finally, it is worth noting that subtypes discovered by using
data-driven methods are not observed but are latent by nature and
ideally should not be referred to as ‘‘phenotypes’’ (ie, observable
characteristics). However, because the term ‘‘phenotype’’ has
been used in this context for more than a decade, we have
maintained this nomenclature.
TABLE III. Lung function at age 24 years by wheeze phenotype (restricted to 1343 participants with FEV1 percent predicted data
and 1351 with FEV1/FVC data)
Wheeze phenotypes, 0-16½ y
Baseline lung function at 24 y Postbronchodilator lung function at 24 y
FEV1 (% predicted) FEV1/FVC ratio FEV1 (% predicted) FEV1/FVC ratio
No. Mean (SD) No. Mean (SD) No. Mean (SD) No. Mean (SD)
Never infrequent 1004 95.0 (11.7) 1009 0.84 (0.06) 830 97.9 (11.7) 834 0.86 (0.06)
Transient early
Preschool remitting 329 93.4 (11.4) 330 0.82 (0.07) 274 96.8 (10.9) 275 0.85 (0.06)
Midchildhood remitting 89 93.5 (11.4) 91 0.82 (0.06) 71 97.5 (11.8) 73 0.84 (0.05)
Late onset
School-age onset 61 95.4 (11.2) 61 0.81 (0.08) 47 100.8 (10.8) 47 0.86 (0.06)
Late-childhood onset 79 94.0 (12.1) 80 0.82 (0.07) 62 98.7 (10.8) 63 0.85 (0.05)
Persistent wheeze 80 91.6 (12.4) 80 0.79 (0.09) 59 96.5 (11.1) 59 0.83 (0.07)
FVC, Forced vital capacity.
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Anumber of previous studies (including our own) embarked on
identifying wheeze phenotypes from birth to mid–school age
(summarized in Table E4 in this article’s Online Repository at
www.jacionline.org). However, the inconsistency of findings
has led to a debate on the validity and clinical value of
phenotyping studies,10,31,32 hampering the discovery of
pathophysiologic endotypes and translation into clinically
actionable insights. The 4 phenotypes of persistent, never,
transient early, and late-onset wheezing have been long postulated
in descriptive2 and data-driven33 studies. We found that when the
sample size is relatively small, a particular wheeze phenotype that
exists in the population might be undetectable. Therefore
relatively smaller sample size in some studies might have
contributed to the inability to detect intermediate wheeze
phenotypes with a relatively low prevalence. Using more time
points allowed identification of less common phenotypes (<5%
frequency) by increasing possible response patterns. When the
data collection was frequent (>11 time points), a sample size of
approximately 2500 was found to be sufficiently large to
distinguish 6 phenotypes. However, even a larger sample size of
3167 might be insufficient to detect uncommon phenotypes
(<5% frequency) under certain conditions (eg, data collection
points <11). Our findings suggest that increasing data collection
frequency might help compensate for a modest sample size in
phenotype identification. In line with this finding, Depner
et al30 identified an intermediate phenotype in the PASTURE
cohort that existed during the first 6 years of life by using a similar
sample size but more data collection points than those used in the
TCRS.2 However, the selection of follow-up points needs careful
thought. Our analyses have shown that although adding more
time points to the latent model increased the number of
identified phenotypes with distinguishable interpretations, in
some cases the same number of randomly selected data
collection points resulted in a different optimal solution. This
suggests that the timing and distribution of follow-up is important
and that theremight be critical data collection points that are more
informative than others. A variable selection method that we
applied to the data identified 6 time points that were not carrying
additional useful information (months 6, 30, 69, 103, 128, and
198).
The proportion of asthmatic patients was greatest in the
persistent wheeze phenotype (98.5%), and subjects in thisphenotype had diminished prebronchodilator and postbroncho-
dilator lung function (at the time of maximally attained
physiologic lung function plateau29) compared with all other
phenotypes. The proportion of asthmatic patients differed
between intermediate phenotypes (15.1% and 75.3% in 2
transient early phenotypes, preschool remitting andmidchildhood
remitting, respectively; 91.3% and 70.0% in 2 late-onset
phenotypes, late childhood and school-age onset, respectively).
These findings suggest that all phenotypes are distinct and that
this might be a true classification. However, we acknowledge
that the observed associations might also be a proxy of severity.
The preschool-onset remitting phenotype mostly overlapped
with no asthma (94%), but the prebronchodilator and
postbronchodilator lung function at age 24 years was significantly
lower in this class compared with the never/infrequent wheeze
phenotype. Although this can be seen as a contradiction, we
would stress that diminished lung function does not equate to
asthma.29 There is evidence that early transient wheezing is
associated with low lung function34-37; as lungs/airways grow,
the symptoms regress, but lung function impairment can persist.
In TCRS the lowest infant lung function test values were
associated with low lung function at 22 years,38 and therefore
early wheezing that remits might be amarker of low lung function
in early life that persists to adulthood but without the development
of airway inflammation or asthma.
In conclusion, our findings add to the understanding of
childhood wheeze phenotypes by extending the knowledge on
potential causes of variability in classification of wheezing.
Sample size, frequency, and timing of data collection have a
major influence on the number and type of phenotypes identified
by using data-driven techniques. Our results, which include
information on the most informative follow-up points, are
important to interpret (or reanalyze) existing studies and to
inform better design of future cohorts. However, we wish to note
that these data collection points should not be regarded as
absolute; rather, they should be treated as relative values with
respect to our population and considerations for investigators
when designing future studies.
We thank all the families who took part in this study, the midwives for their
help in recruiting them, and the whole ALSPAC team, which includes
interviewers, computer and laboratory technicians, clerical workers, research
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points; model dimensionality; and combinations of these
factors.
d Not all data collection points carry useful information in
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METHODS
Study design
This was an unselected birth cohort study.
Setting
ALSPAC is based on the former administrative County of Avon, United
Kingdom covering a population of approximately 0.9 million.
Screening and recruitment
ALSPAC initially recruited 14,541 pregnant women residing in Avon,
United Kingdom, with expected dates of delivery between April 1, 1991, and
December 31, 1992. This initial number of pregnancies, known as the core
sample, included mothers enrolled in ALSPAC and had either returned at least
1 questionnaire or attended a Children in Focus research clinic by July 19,
1999. These initial pregnancies had a total of 14,676 fetuses, resulting in
14,062 live births and 13,988 children who were alive at age 1 year. When the
oldest children were approximately 7 years of age, an attempt was made to
bolster the initial sample with eligible cases who had not joined the study
originally. As a result, there are extra data available when considering
variables collected from the age of 7 years onward. The number of new
pregnancies not in the core sample, known as phase II and III enrollments, is
706 (452 and 254 recruited during phases II and III, respectively), resulting in
an additional 713 children being enrolled. The phases of enrollment are
described in more detail in the cohort profile paper.E1,E2 Therefore the total
sample size for analyses using any data collected after the age of 7 years is
15,247 pregnancies, resulting in 15,458 fetuses with 14,775 live births and
14,701 alive children at 1 year of age.
Spirometry
Spirometry was performed according to American Thoracic Society/
European Respiratory Society guidelinesE3,E4 with a Vitalograph pneumota-
chograph system using animated incentive software (Spirotrac; Vitalograph,
Maids Moreton, United Kingdom) in a dedicated research clinic by trained
technicians. Calibration checks were performed with a standard 3-L calibra-
tion syringe, according to the manufacturer’s instructions, at the start of
each half-day clinic session. Subjects were seated with a nose clip in place
and were asked to inhale to total lung capacity and then instructed to perform
a forced expiration through a mouthpiece to residual volume. The test was
repeated at intervals of 30 seconds until 3 technically acceptable traces
were obtained from a maximum of 8 attempts. FEV1 and forced vital capacity
were recorded, and data were expressed as FEV1 percent predicted and FEV1/
forced vital capacity ratio.
Definition of outcomes
Current wheezewas defined as a positive answer to the following question:
‘‘In the last 12 months has he/she had any periods when there was wheezing or
wheezing with whistling on his/her chest when he/she breathed?’’
Current asthma was defined as self-reported current asthma at 23 years
based on asthma ever at age 22 years or greater together with current wheezing
and/or current treatment: ‘‘Haveyou had anywheezing in the past 12months?’’
and/or ‘‘Have you taken asthma medication in the last 12 months?’’
Asthma ever was defined as a positive answer to the question ‘‘Have you
ever had asthma?’’ at age 22 years or greater.
Study data were collected and managed with REDCap electronic data
capture tools hosted at ALSPAC facilities.E5 Please note that the study Web
site contains details of all the data that are available through a fully searchable
data dictionary and variable search tool (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary/).
Statistical analysis
Measures of fit in LCA. An optimal model is defined as the free
model that best fits the data. To assess model fit, we used (1) the BIC, a
function of the likelihood that rewards parsimony, and (2) entropy, an
assessment of model classification based on the posterior class membership
probabilities. The BIC is an index used in Bayesian statistics to choose among
a set of competing models; the model with the lowest BIC is preferred.
Entropy is a measure of classification certainty that that ranges from 0 to 1,
with values near 1 indicating a clear delineation of classes and values near
0 indicating low certainty in classification.
Selection of informative data collection points. A
genetic algorithmwas used to search for the optimal set of clustering variables
(eg, time points) to distinguish wheezing subgroups by using the LCAvarsel R
package.E6 During the search, multiple sets of clustering variables were
considered at the same time; then, for each set, an LCA model was estimated
on the clustering variables, and a regression/independence model was esti-
mated on the nonclustering variables. Different sets were generated by various
genetic operators, and the fittest subjects were selected. The fitness function
was defined as the BIC of the joint distribution of both clustering and nonclus-
tering variables, where clustering variables were modeled through an LCA
model and nonclustering variables weremodeled throughmultinomial logistic
regression. Variable specific entropy contribution of each time point was used
to assess how well individual time points identified latent classes. These uni-
variate entropies varying between 0 and 1 were directly comparable with each
other, with large values indicating the clear separation of classes.
TheRand index andARIwere used as similaritymeasures when comparing
different clustering results.More specifically, the ARIwas used tomeasure the
level of agreement between 2 partitions, the model fitted to the data subset and
the full data set. A larger Rand index and ARI means greater agreement
between 2 partitions.
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FIG E1. Optimal number, shape, and prevalence of wheeze phenotypes with different (12,290, 7,500, 5,000,
2,500, 1,500, and 500) sample sizes based on children with at least 2 observations of wheezing (the optimal
phenotype was chosen based on the lowest BIC).
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FIG E2. Heat map showing the phi coefficient of pairwise comparison between data collection points.
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FIG E3. Optimal number, shape, and prevalence of wheeze phenotypes with different numbers of data
collection points (6, 8, 11, and 14) based on children with at least 2 observations of wheeze.
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FIG E4. Optimal number, shape, and prevalence of wheeze phenotypes with combined effects of sample
size and data collection frequency based on children with at least 2 observations of wheeze.
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FIG E5. Estimated prevalence of wheeze for each wheeze phenotype in 4, 5, and 6 latent class solutions
identified by using LCA based on 12,290 children with at least 2 observations of wheeze.
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FIG E6. Assignment of children into distinct wheeze phenotypes over a sequence of latent class models
with 4, 5, and 6 classes based on most likely class membership (12,290 children with at least 2 observations
of wheezing). Ellipse nodes show class membership (most likely phenotype), whereas values along the
arrow represent the percentage of children moving from one class to another in models with an increasing
number of classes.
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TABLE E1. Differences in lung function (FEV1 percent predicted) at 24 years between wheeze phenotypes: ANOVA and Tukey HSD
test of pairwise comparisons
ANOVA
Variation
source
df Sum square Mean square F value Pr(>F)
Pre-BD
FEV1
% predicted
Post-BD
FEV1
% predicted
Pre-BD
FEV1
% predicted
Post-BD
FEV1
% predicted
Pre-BD
FEV1
% predicted
Post-BD
FEV1
% predicted
Pre-BD
FEV1
% predicted
Post-BD
FEV1
% predicted
Pre-BD
FEV1
% predicted
Post-BD
FEV1
% predicted
Phenotypes 5 5 2,243 1,463 448.6 292.6 3.313 2.252 0.005561 0.04709
Residual 1,651 1,351 223,565 175,521 135.4 129.9
Tukey HSD test
Pairwise comparison of wheeze phenotypes
Mean Differences Significant (P adjusted< .05)?
95% CI of differences (lower, to
upper)
Pre-BD FEV1
% predicted
Post-BD FEV1
% predicted
Pre-BD FEV1
% predicted
Post-BD FEV1
% predicted
Pre-BD FEV1
% predicted
Post-BD FEV1
% predicted
Midchildhood remitting AND late-childhood onset 20.66 21.61 No No 25.82 to 4.49 27.27 to 4.05
Never/infrequent AND late-childhood onset 0.69 21.34 No No 23.11 to 4.50 25.52 to 2.84
Preschool remitting AND late-childhood onset 21.59 23.11 No No 25.78 to 2.60 27.69 to 1.47
Persistent AND late-childhood onset 23.26 23.41 No No 28.44 to 1.93 29.26 to 2.44
School-age onset AND late-childhood onset 1.51 1.70 No No 24.11 to 7.12 24.45 to 7.86
Never/infrequent AND midchildhood remitting 1.36 0.27 No No 22.40 to 5.12 23.85 to 4.39
Preschool remitting AND midchildhood remitting 20.93 21.50 No No 25.08 to 3.22 26.03 to 3.03
Persistent AND midchildhood remitting 22.59 21.80 No No 27.75 to 2.56 27.61 to 4.00
School-age onset AND midchildhood remitting 2.17 3.31 No No 23.42 to 7.76 22.80 to 9.43
Preschool remitting AND never/infrequent 22.29 21.77 Yes No 24.55 to 20.02 24.20 to 0.66
Persistent AND never/infrequent 23.95 22.07 Yes No 27.76 to 20.15 26.45 to 2.30
School-age onset AND never/infrequent 0.81 3.04 No No 23.56 to 5.18 21.73 to 7.82
Persistent AND preschool remitting 21.66 20.30 No No 25.86 to 2.52 25.06 to 4.46
School-age onset AND preschool remitting 3.10 4.81 No No 21.61 to 7.81 20.32 to 9.94
School-age onset AND persistent 4.77 5.12 No No 20.85 to 10.38 21.17 to 11.4
Significant differences are in boldface.
HSD, Honestly significant difference.
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TABLE E2. Differences in lung function (FEV1/FVC ratio) at 24 years between wheeze phenotypes: ANOVA and Tukey HSD test of
pairwise comparisons
ANOVA
Variation
source
df Sum square Mean square F value Pr(>F)
Pre-BD
FEV1/FVC
ratio
Post-BD
FEV1/FVC
ratio
Pre-BD
FEV1/FVC
ratio
Post-BD
FEV1/FVC
ratio
Pre-BD
FEV1/FVC
ratio
Post-BD
FEV1/FVC
ratio
Pre-BD
FEV1/FVC
ratio
Post-BD
FEV1/FVC
ratio
Pre-BD
FEV1/FVC
ratio
Post-BD
FEV1/FVC
ratio
Phenotypes 5 5 0.3269 0.1527 0.06539 0.03054 14.51 8.33 6.2E-14 9.0E-08
Residual 1600 1358 7.482 4.977 0.00451 0.00366
Tukey HSD test
Pairwise comparison of wheeze phenotypes
Mean Differences Significant (P adjusted < .05)?
95% CI of differences (lower to
upper)
Pre-BD
FEV1/FVC ratio
Post-BD
FEV1/FVC ratio
Pre-BD
FEV1/FVC ratio
Post-BD
FEV1/FVC ratio
Pre-BD
FEV1/FVC ratio
Post-BD
FEV1/FVC ratio
Midchildhood remitting AND late-childhood onset 0.01 20.01 No No 20.02 to 0.04 20.04 to 0.02
Never/infrequent AND late-childhood onset 0.02 0.01 No No 0.00 to 0.04 20.02 to 0.03
Preschool remitting AND late-childhood onset 0.00 20.01 No No 20.03 to 0.02 20.04 to 0.01
Persistent AND late-childhood onset 20.03 20.03 No No 20.06 to 0.00 20.06 to 0.00
School-age onset AND late-childhood onset 0.00 0.00 No No 20.04 to 0.03 20.03 to 0.03
Never/infrequent AND midchildhood remitting 0.01 0.02 No No 20.01 to 0.04 0.00 to 0.04
Preschool remitting AND midchildhood remitting 20.01 0.00 No No 20.04 to 0.01 20.02 to 0.02
Persistent AND midchildhood remitting 20.03 20.02 Yes No 20.06 to 0.00 20.05 to 0.01
School-age onset AND midchildhood remitting 20.01 0.01 No No 20.04 to 0.02 20.02 to 0.04
Preschool remitting AND never/infrequent 20.03 20.02 Yes Yes 20.04 to 20.01 20.03 to 20.01
Persistent AND never/infrequent 20.05 20.04 Yes Yes 20.07 to 20.03 20.06 to 20.01
School-age onset AND never/infrequent 20.03 20.01 Yes No 20.05 to 0.00 20.03 to 0.02
Persistent AND preschool remitting 20.02 20.02 No No 20.05 to 0.00 20.04 to 0.01
School-age onset AND preschool remitting 0.00 0.01 No No 20.03 to 0.03 20.01 to 0.04
School-age onset AND persistent 0.02 0.03 No No 20.01 to 0.05 0.00 to 0.06
Significant differences are in boldface.
FVC, Forced vital capacity; HSD, honestly significant difference.
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TABLE E3. FEV1 reversibility at age 24 years by phenotype (restricted to 1364 participants with FEV1 reversibility data)
Wheeze phenotypes, 0-16½ y
FEV1 reversibility at 24 y
P value* Percent positive FEV1 reversibility (optional)No. Mean (SD)
Never-infrequent 898 2.87 (6.2) Baseline 80.0
Transient early
Preschool remitting 224 4.02 (5.4) 0.104 81.3
Midchildhood remitting 69 4.03 (5.3) 0.627 84.1
Late onset
School-age onset 49 4.94 (4.9) 0.171 89.8
Late-childhood onset 65 4.22 (5.4) 0.490 83.1
Persistent wheeze 59 6.29 (5.9) 0.0003 91.5
*Tukey test.
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TABLE E4. Wheeze phenotypes from birth up to 9 years of age identified based on temporal pattern
Cohort Sample Size No. of time points Years covered No. of phenotypes
CCCEHE7 689 15 9 4
TUSCONE8 826 2 6 4
PASTUREE9 953 6 6 5
MAASE10 1184 8 8 5
PIAMAE11 2810 8 8 5
ALSPACE11 5760 8 8 6
ALSPACE12 6265 7 7 6
CCCEH, Columbia Center for Children’s Environmental Health; MAAS, Manchester Asthma and Allergy Study; PASTURE, Protection against Allergy—Study in Rural
Environments; PIAMA, Prevention and Incidence of Asthma and Mite Allergy; TUCSON, Tucson Children’s Respiratory Study.
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